Share Twitter LinkedIn Facebook Email Nizar M. Tannir, MD, FACP, Professor and Deputy Chair, GU Medical Oncology, MD Anderson presents Cabozantinib is the best salvage therapy for RCC at the 2016 annual International Kidney Cancer Symposium.
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read